2012-02-04 SLAS 2012

SLAS 2012 - 1st Annual Conference and Exhibition
February 4-8, 2012  San Diego, CA, USA

 http://www.slas2012.org/index.cfm

In February 2012, the Society for Laboratory Automation and Screening (SLAS) proudly hosts SLAS2012, the First Annual SLAS Conference and Exhibition. SLAS2012 unites the scientific savvy, technical innovation and energy of the former LabAutomation and SBS conferences to increase collaboration and prominence for the laboratory science and technology community.

SLAS2012 brings together leaders in the scientific community working in drug discovery and development efforts, as well as clinical diagnostics, food and agricultural sciences, forensics and security sciences, petrochemicals and energy, and consumer products.

Delivering a world-class scientific program, SLAS2012 advances areas such as:

• Assay Development and Screening
• High-Throughput Technologies
• Drug Target Biology
• Micro- and Nanotechnologies
• Bioanalytical Techniques
• Informatics
• Diagnostics

Additionally, SLAS2012 will host a robust, vibrant exhibition with hundreds of companies from around the world showcasing the latest and most innovative new technologies; a unique, in-depth learning experience through short courses offering a deep dive into important scientific topics; a series of impactful keynote speakers, including Peter G. Schultz, Ph.D., Scripps Family Chair Professor, Department of Chemistry, The Scripps Research Institute; and a well-rounded roster of podium presenters who are leaders in their field. In addition, SLAS2012 offers a global perspective, practical ideas, industry-changing innovations, an extensive awards program and the opportunity for all to network and knowledge-share.

Take part in the scientific savvy, technical innovation and energy of SLAS2012!

2012-02-12 Keystone Symposium: Chemical Biology and Novel Tools in Pharmacology

Keystone Symposium: Chemical Biology and Novel Tools in Pharmacology
Febryary 12-16, 2012.  Santa Fe, NM, USA

http://www.keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1096&subTab=program

The best solutions to the most important problems in biomedical science have come from multi-disciplinary research. The discovery of new chemical probes and therapeutics requires cross-cutting expertise and the innovative application of new technologies. Scientific forums have become increasingly specialized and narrow in their scope. The specific purpose of the Keystone Symposia meeting on Chemical Biology and Novel Tools in Pharmacology is to initiate and foster active discussions between academic and industrial researchers in the broader area of pharmacological tools. Rather than focus on a specific disease, model system or technical method, this meeting will bring together a variety of experts whose primary, common trait is their innovative use of chemical and biological approaches to solve important problems in biology. From this organizing principle, the specific aims of this meeting are: (a) to assemble chemists and biologists who may not normally interact with each other; (b) to make new connections between chemists and biologists, academics and industrial scientists; and (c) to provide a forum for an open discourse of modern, cross-platform ideas. An unintended consequence of increasingly specialized forums for scientific discussion is the lack of mechanisms for dissemination of novel ideas, platforms and methodologies. The major innovation of this meeting is that it is designed to encourage and inspire researchers to explore and implement inter-disciplinary, emerging methods in chemical biology and pharmacology to their specific biological questions.

2012-03-19 High throughput screening in theory and practice, 1-2 ECTS

The Laboratories for Chemical Biology Umeå (LCBU) and The Laboratory for Molecular Infection Medicine Sweden (MIMS) organise a course in High throughput screening in theory and practice, 1-2 ECTS

Theoretical course 19 - 20 March 2012, 1 ECTS Theoretical + Practical course 19 - 23 March 2012, 2 ECTS

Registration deadline: 27 February 2012

More information here:

http://www.mims.umu.se/courses

2012-03-19 Keystone Symposium: Adressing the Chellenges of Drug Discovery

Keystone Symposium: Adressing the Chellenges of Drug Discovery
March 19-23, 2012.  Tahoe City, NV, USA

http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1150

The scientific and organizational landscape that underpins drug discovery is in a state of rapid evolution. The cellular signal transduction processes and biochemical pathways that enable life are increasingly understood at the molecular level and hypotheses for disease intervention can be proposed within this rational context. Technology to enable discovery of ligands to perturb the function of biological targets continues to advance and new methods to create small molecule tools to interrogate biological processes and potentially serve as drug leads are under development. However, while industry investment in R&D has grown exponentially, approval of new medicines has remained constant for several decades. Juxtaposition of this scientific opportunity, the continuing societal need for new drugs, and a failing model for translation of basic research into new medicines provides fertile soil for new ideas and approaches. This meeting will focus on addressing these challenges in drug discovery with an emphasis on novel biological targets, new chemical space and emerging organizational approaches to more effective translation. The goals of the meeting are: • To explore relatively uncharted protein target class families to define new druggable biological space • To survey promising new chemical approaches for ligand discovery • To highlight new organizational constructs for drug discovery with an emphasis on public/private partnerships The meeting aims to bring together medicinal chemists, disease biologists, chemical biologists, assay developers, and screeners from industry and academics, along with leaders of R&D organizations to create a dynamic exchange around the challenges facing drug discovery.

2012-03-20 2nd RSC Symposium on Chemical Biology for Drug Discovery

2nd RSC Symposium on Chemical Biology for Drug Discovery
March, 20-21, 2012.  Macclesfield, UK

http://www.maggichurchouseevents.co.uk/bmcs/

This symposium covers progress in the interdisciplinary field of Chemical Biology in enhancing our understanding of the molecular mechanisms of human biology in health and disease.

Topics will include discovery and use of chemical probes, chemical modification of biological molecules, in-cell protein labelling, carbohydrate therapeutics and biomarkers, and the study of protein-protein interactions.